Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Grinsztejn, Beatriz"'
Autor:
Turley, Christine B, Tables, LaKesha, Fuller, Trevon, Sanders, Lisa J, Scott, Hyman, Moodley, Amaran, Woodward Davis, Amanda, Leav, Brett, Miller, Jacqueline, Schoemaker, Kathryn, Vandebosch, An, Sadoff, Jerald, Woo, Wayne, Cho, Iksung, Dunkle, Lisa M, Li, Sijia, van der Laan, Lars, Gilbert, Peter B, Follmann, Dean, Jaynes, Holly, Kublin, James G, Baden, Lindsey R, Goepfert, Paul, Kotloff, Karen, Gay, Cynthia L, Falsey, Ann R, El Sahly, Hana M, Sobieszczyk, Magdalena E, Huang, Yunda, Neuzil, Kathleen M, Corey, Lawrence, Grinsztejn, Beatriz, Gray, Glenda, Rouphael, Nadine, Luedtke, Alex, COVID-19 Prevention Network CoVPN
Questions remain regarding the effect of baseline host and exposure factors on vaccine efficacy (VE) across pathogens and vaccine platforms. We report placebo-controlled data from four Phase 3 COVID-19 trials during the early period of the pandemic.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::e1647f2c40df82233aed63676ef8173b
https://escholarship.org/uc/item/9299m028
https://escholarship.org/uc/item/9299m028
Autor:
Marzinke, Mark A, Fogel, Jessica M, Wang, Zhe, Piwowar-Manning, Estelle, Kofron, Ryan, Moser, Amber, Bhandari, Pradip, Gollings, Ryann, Bushman, Lane R, Weng, Lei, Halvas, Elias K, Mellors, John, Anderson, Peter L, Persaud, Deborah, Hendrix, Craig W, McCauley, Marybeth, Rinehart, Alex R, St Clair, Marty, Ford, Susan L, Rooney, James F, Adeyeye, Adeola, Chariyalertsak, Suwat, Mayer, Kenneth, Arduino, Roberto C, Cohen, Myron S, Grinsztejn, Beatriz, Hanscom, Brett, Landovitz, Raphael J, Eshleman, Susan H
Publikováno v:
Antimicrobial agents and chemotherapy, vol 67, iss 4
HPTN 083 demonstrated that injectable cabotegravir (CAB) was superior to oral tenofovir disoproxil fumarate-emtricitabine (TDF-FTC) for HIV prevention in cisgender men and transgender women who have sex with men. We previously analyzed 58 infections
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::03681b83244d85030ecfe1a2c6d4f5b1
https://escholarship.org/uc/item/45066260
https://escholarship.org/uc/item/45066260
Autor:
Eshleman, Susan H, Fogel, Jessica M, Halvas, Elias K, Piwowar-Manning, Estelle, Marzinke, Mark A, Kofron, Ryan, Wang, Zhe, Mellors, John, McCauley, Marybeth, Rinehart, Alex R, St Clair, Marty, Adeyeye, Adeola, Hinojosa, Juan C, Cabello, Robinson, Middelkoop, Keren, Hanscom, Brett, Cohen, Myron S, Grinsztejn, Beatriz, Landovitz, Raphael J, HPTN 083 Study Team
Publikováno v:
The Journal of infectious diseases, vol 226, iss 12
BackgroundThe HPTN 083 trial demonstrated that long-acting cabotegravir (CAB-LA) was superior to tenofovir-disoproxil fumarate/emtricitabine for human immunodeficiency virus (HIV) preexposure prophylaxis (PrEP). Integrase strand transfer inhibitor (I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::1339737053b183c2343514052820ff5e
https://escholarship.org/uc/item/7g8678vk
https://escholarship.org/uc/item/7g8678vk
Autor:
Perazzo, Hugo, Cardoso, Sandra W, Ribeiro, Maria Pia D, Moreira, Rodrigo, Coelho, Lara E, Jalil, Emilia M, Japiassú, André Miguel, Gouvêa, Elias Pimentel, Nunes, Estevão Portela, Andrade, Hugo Boechat, Gouvêa, Luciano Barros, Ferreira, Marcel Treptow, Rodrigues, Pedro Mendes de Azambuja, Moreira, Ronaldo, Geraldo, Kim, Freitas, Lucilene, Pacheco, Vinicius V, João, Esau Custódio, Fuller, Trevon, Rocha, Verônica Diniz, Nunes, Ceuci de Lima Xavier, Souza, Tâmara Newman Lobato, Toscano, Ana Luiza Castro Conde, Schwarzbold, Alexandre Vargas, Noal, Helena Carolina, Pinto, Gustavo de Araujo, Lemos, Paula Macedo de Oliveira, Santos, Carla, Mello, Fernanda Carvalho de Queiroz, Veloso, Valdilea G, Grinsztejn, Beatriz, RECOVER-SUS Brasil Group
BackgroundWe evaluated in-hospital mortality and outcomes incidence after hospital discharge due to COVID-19 in a Brazilian multicenter cohort.MethodsThis prospective multicenter study (RECOVER-SUS, NCT04807699) included COVID-19 patients hospitalize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::9c8efb343ffa13bf45ff2b5fb0e0bfa2
https://escholarship.org/uc/item/0kc2g7kg
https://escholarship.org/uc/item/0kc2g7kg
Autor:
Marzinke, Mark A, Grinsztejn, Beatriz, Fogel, Jessica M, Piwowar-Manning, Estelle, Li, Maoji, Weng, Lei, McCauley, Marybeth, Cummings, Vanessa, Ahmed, Shahnaz, Haines, Casey D, Bushman, Lane R, Petropoulos, Christos, Persaud, Deborah, Adeyeye, Adeola, Kofron, Ryan, Rinehart, Alex, St Clair, Marty, Rooney, James F, Pryluka, Daniel, Coelho, Lara, Gaur, Aditya, Middelkoop, Keren, Phanuphak, Nittaya, Cohen, Myron S, Hendrix, Craig W, Anderson, Peter, Hanscom, Brett, Donnell, Deborah, Landovitz, Raphael J, Eshleman, Susan H
Publikováno v:
The Journal of infectious diseases, vol 224, iss 9
BackgroundThe HIV Prevention Trials Network (HPTN) 083 trial demonstrated that long-acting cabotegravir (CAB-LA) was more effective than tenofovir disoproxil fumarate-emtricitabine (TDF/FTC) in preventing human immunodeficiency virus (HIV) in cisgend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::a5b31cc3aebf0ee1f864d192eeadafed
https://escholarship.org/uc/item/3133r6jx
https://escholarship.org/uc/item/3133r6jx
Autor:
Marzinke, Mark A, Grinsztejn, Beatriz, Fogel, Jessica M, Piwowar-Manning, Estelle, Li, Maoji, Weng, Lei, McCauley, Marybeth, Cummings, Vanessa, Ahmed, Shahnaz, Haines, Casey D, Bushman, Lane R, Petropoulos, Christos, Persaud, Deborah, Adeyeye, Adeola, Kofron, Ryan, Rinehart, Alex, St Clair, Marty, Rooney, James F, Pryluka, Daniel, Coelho, Lara, Gaur, Aditya, Middelkoop, Keren, Phanuphak, Nittaya, Cohen, Myron S, Hendrix, Craig W, Anderson, Peter, Hanscom, Brett, Donnell, Deborah, Landovitz, Raphael J, Eshleman, Susan H
Publikováno v:
The Journal of infectious diseases, vol 224, iss 9
IntroductionThe HIV Prevention Trials Network (HPTN) 083 trial demonstrated that long-acting cabotegravir (CAB-LA) was more effective than tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) for HIV prevention in cisgender men and transgender women
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::95eff7d5d579eafc7b83cbf58dd97cc5
https://escholarship.org/uc/item/3133r6jx
https://escholarship.org/uc/item/3133r6jx
Autor:
Tolley, Elizabeth E, Zangeneh, Sahar Z, Chau, Gordon, Eron, Joe, Grinsztejn, Beatriz, Humphries, Hilton, Liu, Albert, Siegel, Marc, Bertha, Maseko, Panchia, Ravindre, Li, Sue, Cottle, Leslie, Rinehart, Alex, Margolis, David, Jennings, Andrea, McCauley, Marybeth, Landovitz, Raphael J
Publikováno v:
AIDS and behavior, vol 24, iss 9
Long-acting injectable PrEP could offer an alternative to daily oral PrEP, improve adherence and protection, if found acceptable, safe and effective. HPTN 077 evaluated injectable cabotegravir safety, tolerability and pharmacokinetics among HIV-uninf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c1802f65aac772e71c7505a547178d70
https://escholarship.org/uc/item/0pf9h9x6
https://escholarship.org/uc/item/0pf9h9x6
Autor:
Landovitz, Raphael J, Zangeneh, Sahar Z, Chau, Gordon, Grinsztejn, Beatriz, Eron, Joseph J, Dawood, Halima, Magnus, Manya, Liu, Albert Y, Panchia, Ravindre, Hosseinipour, Mina C, Kofron, Ryan, Margolis, David A, Rinehart, Alex, Adeyeye, Adeola, Burns, David, McCauley, Marybeth, Cohen, Myron S, Currier, Judith S
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 70, iss 2
Studies in human immunodeficiency virus (HIV)-infected individuals suggest excess weight gain with integrase inhibitor-based antiretroviral therapy. The HIV Prevention Trials Network Study 077 evaluated changes in weight and fasting metabolic paramet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::11c7de668060db297990bccfab518c08
https://escholarship.org/uc/item/71p6q7tf
https://escholarship.org/uc/item/71p6q7tf
Autor:
Coelho, Lara Esteves, Torres, Thiago Silva, Veloso, Valdiléa Gonçalves, Landovitz, Raphael J, Grinsztejn, Beatriz
Publikováno v:
The lancet. HIV, vol 6, iss 11
Pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate and emtricitabine was adopted by WHO as a strategy to reduce HIV incidence. Although shown to be highly effective in reducing HIV acquisition, the protective efficacy of oral tenofovi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::dcf40e3b48d569c929f7b93160ad580b
https://escholarship.org/uc/item/83m239cs
https://escholarship.org/uc/item/83m239cs
Autor:
Caniglia, Ellen C, Robins, James M, Cain, Lauren E, Sabin, Caroline, Logan, Roger, Abgrall, Sophie, Mugavero, Michael J, Hernández-Díaz, Sonia, Meyer, Laurence, Seng, Remonie, Drozd, Daniel R, Seage Iii, George R, Bonnet, Fabrice, Le Marec, Fabien, Moore, Richard D, Reiss, Peter, van Sighem, Ard, Mathews, William C, Jarrín, Inma, Alejos, Belén, Deeks, Steven G, Muga, Roberto, Boswell, Stephen L, Ferrer, Elena, Eron, Joseph J, Gill, John, Pacheco, Antonio, Grinsztejn, Beatriz, Napravnik, Sonia, Jose, Sophie, Phillips, Andrew, Justice, Amy, Tate, Janet, Bucher, Heiner C, Egger, Matthias, Furrer, Hansjakob, Miro, Jose M, Casabona, Jordi, Porter, Kholoud, Touloumi, Giota, Crane, Heidi, Costagliola, Dominique, Saag, Michael, Hernán, Miguel A
Publikováno v:
Statistics in medicine, vol 38, iss 13
Decisions about when to start or switch a therapy often depend on the frequency with which individuals are monitored or tested. For example, the optimal time to switch antiretroviral therapy depends on the frequency with which HIV-positive individual
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::d94ef8d632951ec44d479e655a61aa72
https://escholarship.org/uc/item/24m9p9p9
https://escholarship.org/uc/item/24m9p9p9